search

The Luxembourg BioHealth Cluster managed by Luxinnovation aims to strengthen and capitalise on the national strategy developed by Luxembourg’s government to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine.

Its members are R&D companies, public research organisations, laboratories, hospitals and other actors (patients associations, service and capital providers, etc.) whose activities are related to health sciences and technologies.

The main focus of the Cluster is personalised medicine, an area in which Luxembourg has identified niche areas of expertise where the country has strong potential to be competitive at a global level: digital health, neurodegenerative diseases, molecular diagnostics and immune-oncology.

Objectives:

  • reinforcing and capitalising on Luxembourg’s national strategy to achieve scientific excellence in molecular diagnostics
  • enhance Luxembourg’s reputation as a recognised and attractive environment for biomedical research, development, innovation (RDI) and business.
  • support the community, help members find new opportunities for advancement here in Luxembourg and abroad, and work with them to articulate their needs and their challenges at a national level.

Did you know...

Stay up to date

Latest news

BTech – Braingineering Technologies

12-01-2018

The latest round of the Horizon 2020 SME Instrument has seen the successful funding of a Luxembourgish SME, Braingineering Technologies, which has been positively evaluated for a Phase 1 project. SMEs...
Read more

Japanese pharma company JCR to set up a manufacturing plant in Luxembourg

19-12-2017

JCR Pharmaceuticals, a Japanese public company engaged in research, development, manufacture and sales of pharmaceuticals, has chosen Luxembourg to set up a new manufacturing plant of Active Pharmaceu...
Read more

LIAB Award 2017: A molecule that fights cancer

27-11-2017

Paul Spagnuolo, a world leader in nutraceutical research, and his discovery of an avocado-based lipid that attacks leukaemia stem cells are the winners of LIST’s first International Award in Bioinnovation (LIAB Award 2017).
Read more

CES 2018: 8 start-ups will represent Luxembourg in Las Vegas!

23-11-2017

The eight Luxembourg start-ups participating in the prestigious CES (Consumer Electronics Show) in Las Vegas from 9 to 12 January were unveiled during an event at the private design club “House 17...
Read more

All news

  • Monday
  • Tuesday
  • Wednesday
  • Thursday
  • Friday
  • Saturday
  • Sunday

Meet us

Upcoming events

17 January 2018

How to write a competitive Horizon 2020 proposal

Esch-sur-Alzette (Luxembourg)

Horizon 2020 is the EU's research and innovation funding programme. It runs from 2014-2020 and has a budget of €80 billion. Read more

25 January 2018

Lecture series and workshops: Prof TURNER

(Luxembourg)

The migration of cancer cells away from the primary tumor mass and the formation of subsequent metastases to distant organs is associated with 90% of cancer mortalities. Importantly, tumor cell behavior, including migration and invasion is strongly influenced the topography, composition and stiffness of the surrounding stromal extracellular matrix environment. Read more

29 > 31 January 2018

Arab Health 2018 accompanied visit

(United Arab Emirates)

The Chamber of Commerce is organising an accompanied visit to Arab Health 2018, January 29-31, 2018, at the Dubai International Convention and Exhibition Center. Read more

All events

Members list

Show members

company / private organisation

MEMBERS CATALOGUE

Other clusters in Luxembourg

Fermer